SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
金金
Lv2
9
136 积分
2024-08-09 加入
最近求助
最近应助
互助留言
Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer
1天前
已完结
Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma
1天前
已完结
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
1天前
已完结
Immunotherapy and Prevention of Cancer by Nanovaccines Loaded with Whole‐Cell Components of Tumor Tissues or Cells
1天前
已完结
Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer
2天前
已关闭
Spatial Immunogenomic Patterns Associated with Lymph Node Metastasis in Lung Adenocarcinoma
2天前
已完结
HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer
2天前
已完结
Activation of Kir4.1/Kir5.1 contributes to the cyclosporin A‐induced stimulation of the renal NaCl cotransporter and hyperkalemic hypertension
3天前
已完结
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study
6天前
已完结
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): a single-arm, phase II study
6天前
已完结
没有进行任何应助
帮大忙了
1天前
暂不需要了【积分已退回】
2天前
感谢
2天前
感谢
2天前
感谢
6天前
点赞
6天前
帮大忙了,速度真快,点赞
6天前
点赞
6天前
感谢
21天前
感谢
22天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论